This activity is supported by an unrestricted educational grant from Gilead Sciences, Inc.

Risk-Stratified Treatment in Chronic Lymphocytic Leukemia

Deborah M. Stephens, DO
Huntsman Cancer Institute

Amy L. Goodrich, MSN, CRNP
Johns Hopkins University

New treatment options and shifting paradigms in the approach and management of CLL patients, present care challenges, especially with newer oral agents.  This activity discusses risk-stratification, targeting pathways and best practices to improve patient outcomes: how/when to incorporate old therapies vs. newer treatments and the management of patients with CLL in this rapidly changing treatment landscape.



 

Download Podcast

  
 
 

Download Transcript

 
 

Download Slides

 
 

Download Slides & Transcripts

  





These CE/CME/CEU accredited activities are jointly provided by

JADPRO Logo    Harborside Press Logo    APSHO Logo    Annenberg Logo
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here
click me